Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

PURPOSE This study was performed to evaluate the potential of specific mRNA markers to detect micrometastases by reverse-transcriptase polymerase chain reaction (RT-PCR) and Southern blot analysis of sentinel lymph nodes (SNs) and blood from patients with breast cancer. PATIENTS AND METHODS We assessed the specificity of carcinoembryonic antigen (CEA), cytokeratin-19 (CK-19), CK-20, gastrointestinal tumor-associated antigen-733.2 (GA733.2), and mucin-1 (MUC-1) in the blood of healthy donors (n = 13) and lymph nodes from patients without cancer (n = 3) by RT-PCR assay. The sensitivity of the RT-PCR assay for the target mRNA markers was assessed in breast cancer cell lines (n = 4), primary breast tumors (n = 8), and the frozen sections of SNs (n = 22) from 22 patients with American Joint Committee on Cancer (AJCC) stages I to IIIA breast cancer. RESULTS CK-20 was the only mRNA marker not detected in lymph nodes or blood from patients without cancer. Both the blood and lymph nodes from patients without cancer expressed CEA, CK-19, GA733.2, and MUC-1 mRNA. All four breast cancer cell lines and six of eight primary breast tumors expressed all five mRNA markers. Expression of mRNA by the RT-PCR assay in the frozen-section SNs (n = 12) without metastases by conventional histopathology ranged from 8% (CK-20) to 92% (GA733.2). Detection of RT-PCR cDNA products in frozen-section SNs was increased with Southern blot analysis compared with ethidium bromide gel electrophoresis (EtBr) for all mRNA markers except CK-19. CONCLUSION CEA, CK-19, GA733.2, and MUC-1 show no diagnostic value as mRNA markers for the detection of micrometastases by the RT-PCR assay because they are expressed in the blood and lymph nodes of patients without cancer. Further studies are needed to assess the sensitivity of CK-20 to detect micrometastases by the RT-PCR assay in the blood and frozen-section SNs of patients with breast cancer.

[1]  S. Hellman,et al.  Karnofsky Memorial Lecture. Natural history of small breast cancers. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  K. Pittman,et al.  Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. , 1995, British Journal of Cancer.

[3]  K. Pantel,et al.  Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  K. Müller,et al.  Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  O. Saphir,et al.  Obscure axillary lymph‐node metastasis in carcinoma of the breast , 1948, The American journal of pathology.

[6]  A. Giuliano,et al.  Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy , 1995, Annals of surgery.

[7]  Donald L. Morton,et al.  Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.

[8]  Shinzaburo Noguchi,et al.  The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase‐polymerase chain reaction , 1994, Cancer.

[9]  K. Mimori,et al.  Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. , 1995, Cancer research.

[10]  T. Aihara,et al.  Detection of Gastric Cancer Micrometastases in Lymph Nodes by Amplification of Keratin 19 mRNA with Reverse Transcriptase‐Polymerase Chain Reaction , 1996, Japanese journal of cancer research : Gann.

[11]  Internationalludwigbreastcanc.  Prognostic importance of occult axillary lymph node micrometastases from breast cancers , 1990 .

[12]  S. Ethier,et al.  Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. T. Traweek,et al.  Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. , 1993, The American journal of pathology.

[14]  H. Juhl,et al.  Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Sandra,et al.  Expression of the gene coding for a human mucin in mouse mammary tumor cells can affect their tumorigenicity. , 1991, The Journal of biological chemistry.

[16]  H. Juhl,et al.  Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. , 1997, Cancer research.

[17]  G. von Minckwitz,et al.  Prospective randomized studies are needed to define the role of axillary lymph node dissection in primary breast cancer. , 1997, Journal of Clinical Oncology.

[18]  L. Moscinski,et al.  High‐sensitivity Detection of Minimal Residual Breast Carcinoma Using the Polymerase Chain Reaction and Primers for Cytokeratin 19 , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[19]  D. Mason,et al.  The immunocytochemical detection of axillary micrometastases in breast cancer. , 1984, British Journal of Cancer.

[20]  Christian Röder,et al.  The detection of disseminated tumor cells in bone marrow from colorectal‐cancer patients by a cytokeratin‐20‐specific nested reverse‐transcriptase‐polymerase‐chain reaction is related to the stage of disease , 1996, International journal of cancer.

[21]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  D. Hoon,et al.  Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine‐activated killer cells , 1989, International journal of cancer.

[23]  B. Garicochea,et al.  Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors. , 1997, Molecular pathology : MP.

[24]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[25]  J. McCall,et al.  Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[26]  H. Frierson,et al.  Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. , 1996, Clinical chemistry.

[27]  G. Castaldo,et al.  Lung cancer metastatic cells detected in blood by reverse transcriptase-polymerase chain reaction and dot-blot analysis. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  S. Shousha,et al.  Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients. , 1996, British Journal of Cancer.

[29]  D. Garrison,et al.  Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  S. Szala,et al.  Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Mimori,et al.  Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease , 1996, International journal of cancer.

[32]  J. McCall,et al.  Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer. , 1997, British Journal of Cancer.

[33]  W. McGuire,et al.  Prognostic factors and therapeutic decisions in axillary node-negative breast cancer. , 1992, Annual review of medicine.

[34]  M. Monden,et al.  Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase‐polymerase chain reaction , 1997, International journal of cancer.

[35]  A. Giuliano,et al.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. , 1997, Annals of surgery.

[36]  D. Speicher,et al.  Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Shinzaburo Noguchi,et al.  Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase‐polymerase chain reaction , 1996, Cancer.

[38]  D. Garrison,et al.  Melanoma-associated antigens as messenger RNA detection markers for melanoma. , 1997, Cancer research.

[39]  J. Torhorst,et al.  Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.